Veterans with osteoporosis risk are identified using a clinical dashboard populated with data from the Veterans Health Administration (VHA) Corporate Data Warehouse (CDW) data on age (e.g., for women ≥ 65; men ≥ 80), evidence of exposure to chronic glucocorticoid therapy (i.e., prednisone), androgen deprivation therapy (i.e., leuprolide), or aromatase inhibitors (i.e., anastrozole), and an Osteoporosis Self‐Assessment Tool (OST)(8, 9, 10, 11) score of ≤1. Here, CYP19A1 is linked to osteoporosis.